Vai al contenuto
Global sound
Conversations in Drug Development

Conversations in Drug Development

Navigating the FDA Landscape: More Changes, and What's Next?

· 27 min · Episodio 24

Note dell’episodio

In this episode, Eric Hardter and guest Kelsey Lenoch discuss recent US FDA developments, including leadership changes at CBER and CDER, staffing impacts on orphan product reviews, and the new Rare Disease Evidence Principles aimed at accelerating approvals for rare and ultra-rare conditions.
They also explore evolving trial endpoints in oncology (including surrogate measures and ctDNA), transparency moves such as the public release of Complete Response Letters and the industry’s reactions, updates on the National Priority Voucher Program, and the FDA Pre-Check initiative to boost domestic…

Sito web: conversationsindrugdevelopmentwithboyds.podbean.com

In diretta, ultima ora: 12.482 brani su 6.016 stazioni in 139 paesi

Scopri il mondo attraverso la radio

Altri modi per scoprire (7)

Hai sentito qualcosa di bello? Salvalo, o aprilo subito in Spotify.

★ Artista della settimana Il brano che sale più in fretta in radio questa settimana
Il tuo brano qui? Da € 9 a settimana →
Y94 WDAYContinua ad ascoltare